首页 | 官方网站   微博 | 高级检索  
     

非小细胞肺癌同期放化疗后重度急性放射性肺炎的预测模型研究
引用本文:王谨,包勇,庄婷婷,张黎,何智纯,台安,马红莲,胡晓,周琦超,彭芳
徐裕金,邓小武,陈明.非小细胞肺癌同期放化疗后重度急性放射性肺炎的预测模型研究[J].中华放射肿瘤学杂志,2013,22(6):455-458.
作者姓名:王谨  包勇  庄婷婷  张黎  何智纯  台安  马红莲  胡晓  周琦超  彭芳
徐裕金
  邓小武  陈明
作者单位:310022 杭州,浙江省放射肿瘤学重点实验室浙江省肿瘤医院放疗科(王谨、马红莲、徐裕金、陈明);
510060广州,中山大学附属肿瘤医院放疗科(包勇、张黎、何智纯、胡晓、周琦超、彭芳、邓小武);
515000汕头大学医学院肿瘤医院放疗科(庄婷婷);
53226美国密尔沃基·威斯康辛医学院放疗科(台安)
基金项目:国家自然科学基金项目(81172126)
摘    要:目的 利用剂量体积直方图(DVH)参数建立Logistic剂量反应及Lyman-Kutcher-Burman正常组织并发症概率(LKB-NTCP)模型,并评估其对非小细胞肺癌同期放化疗后重度急性放射性肺炎(SARP)的预测价值。方法 搜集2006—2010年间行三维适形放疗同期化疗的147例非小细胞肺癌患者资料。按美国RTOG毒性评价标准定义超过3级的ARP为SARP。根据DVH剂量学信息建立Logistic剂量反应模型和LKB-NTCP模型。结果 SARP 发生率为9.5%(14/147)。Logistic剂量反应模型参数:常数b0=-6.66、b1=0.252,TD50=26.43 Gy,γ50=1.67;模型曲线在17 Gy以下相对平坦,17~18 Gy处变为陡峭,SARP风险增大。LKB-NTCP模型参数:体积效应因子n=0.87±0.40,曲线斜率倒数m=0.27±0.10,TD50(1)=(29.5±8.0) Gy;Logistic回归及ROC分析均发现此参数下计算出NTCP值对SARP有良好预测价值(P=0.013、0.019)。结论 NTCP值对SARP的预测价值优于简单剂量参数,2个模型曲线均提示最大限制剂量在约17 Gy。

关 键 词:  非小细胞肺/同期放化疗法  放射性肺损伤  预测模型  
收稿时间:2013-08-01

Study on prediction models for severe acute radiation pneumonitis in patients with non-small cell lung cancer after concurrent chemoradiotherapy
WANG Jin,BAO Yon,ZHUANG Ting-ting,ZHANG Li,HE Zhi-chun,TAI An,MA Hong-Lian,HU Xiao,ZHOU Qi-chao,PENG Fang,XU Yu-jin,DENG Xiao-wu,CHEN Ming..Study on prediction models for severe acute radiation pneumonitis in patients with non-small cell lung cancer after concurrent chemoradiotherapy[J].Chinese Journal of Radiation Oncology,2013,22(6):455-458.
Authors:WANG Jin  BAO Yon  ZHUANG Ting-ting  ZHANG Li  HE Zhi-chun  TAI An  MA Hong-Lian  HU Xiao  ZHOU Qi-chao  PENG Fang  XU Yu-jin  DENG Xiao-wu  CHEN Ming
Affiliation:Department of Radiation Oncology, Zhejiang Cancer Hospital, Key Laboratory of Radiation Oncology in Zhejiang Provnce, Hangzhou 310022, China
Abstract:Objective To establish the Logistic dose response model and Lyman-Kutcher-Burman (LKB)-normal tissue complication probability (NTCP) model using dose-volume histogram (DVH) parameters and to evaluate their predictive values for severe acute radiation pneumonitis (SARP) in patients with non-small cell lung cancer (NSCLC) after concurrent chemotherapy and three-dimensional conformal radiotherapy (3DCRT). Methods The clinical data of 147 NSCLC patients who were treated with concurrent chemotherapy and 3DCRT from 2006 to 2010 were collected. According to RTOG criteria, grade 3 or even severer acute radiation pneumonitis was defined as SARP. The Logistic dose response model and LKB-NTCP model were established according to DVH dosimetric information. Results The incidence of SARP was 9.5%(14/147). The best-fit parameter values for Logistic dose response model were shown as follows:constant b0=-6.66;constant b1=0.252;TD50=26.43 Gy;γ50=1.67. The fit curve was relatively flat when the maximum limit dose (MLD) was<17 Gy, and it became sharper when the MLD was 17-18 Gy, which implied that the risk of SARP increased. The best-fit parameter values for LKB-NTCP model were shown as follows:volume factor n= 0.87±0.40;slope factor m= 0.27±0.10;TD50(1)=(29.5±8.0) Gy. The Logistic regression analysis and receiver operating characteristic (ROC) analysis showed that the NTCP value calculated using the parameter values had a good predictive value for SARP (Logistic regression:P=0.013;area under the ROC curve:0.707,P=0.019). Conclusions The predictive value of NTCP for SARP is better than simple dose parameters. The two model curves suggest that MLD is above 17 Gy.
Keywords:Carcinoma  non-small cell lung/concurrent radio-chemotherapy  Radiation induced lung injury  Forecasting model  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号